Coagulant Therapeutics Announces Publication in Blood Advances Describing Novel Nanobody Library to Activated Protein C (APC) and Initial Leads for Treatment of Trauma and Hemophilia

/PRNewswire/ -- Coagulant Therapeutics Corporation, a privately held company focused on the design, development and commercialization of therapeutics targeted...

Related Keywords

Berkeley ,California ,United States ,American ,Laurent Mosnier ,Eliza Schleifstein ,Terry Hermiston ,Scripps Research Institute ,Site Targeting Nanobody Library ,Journal Of The American Society Hematology ,Antibody Program ,Professor In Department Of Molecular Medicine ,Prnewswire Coagulant Therapeutics Corporation ,Antibody Library ,Coagulant Therapeutics Corporation ,Manuscript Characterizes Novel ,Therapeutics Corporation ,Activated Proteinc Activities ,Non Active Site Targeting Nanobody ,Blood Advances ,American Society ,Coagulant Therapeutics ,Molecular Medicine ,Coagulant Therapeutic ,Vice President ,